2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow Enterocolitis, Necrotizing: new trials by email Literature Review of Enterocolitis, Necrotizing trials Research Report on Enterocolitis, Necrotizing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SMOFlipid to Lessen the Severity of Neonatal Cholestasis SMOFlipid - Cholestasis, Jaundice, Obstructive | Phase 1 / Phase 2 | Terminated | University of Florida | 2 | 2016-05-01 | 2017-04-17 |
| Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome | Phase 1 / Phase 2 | Terminated | Alberta Children's Hospital | 13 | 2012-01-01 | 2014-12-23 |
Cholestasis (1) · Gastroschisis (1) · Hyperphagia (1) · Infant Nutrition Disorders (1) · Intestinal Atresia (1) · Intestinal Failure (1) · Jaundice, Obstructive (1) · Malnutrition (1) · Short Bowel Syndrome (1)
Digestive System Diseases (2) · Enterocolitis (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Abnormalities (1) · Hernia (1) · Hernia, Abdominal (1) · Hyperbilirubinemia (1)
Glucagon-Like Peptide 2 (1) · Parenteral Nutrition (1) · SMOFlipid (1)
Alberta Children's Hospital (1) · University of Florida (1)
Canada (1) · United States (1)
David Sigalet, MD PhD (1) · Josef Neu, MD (1)